Simplex Trading’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Simplex Trading’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,353	Closed	-$4K	–	7185
2016 Q3	$4K	Sell	1,353 -433	-24%	-$1.28K	﹤0.01%	4611
2016 Q2	$7K	Buy	1,786 +1,127	+171%	+$4.42K	﹤0.01%	4014
2016 Q1	$31K	Buy	659 +399	+153%	+$18.8K	﹤0.01%	2418
2015 Q4	$1K	Buy	260 +70	+37%	+$269	﹤0.01%	5238
2015 Q3	$2K	Buy	190 +9	+5%	+$95	﹤0.01%	4879
2015 Q2	$2K	Buy	181 +8	+5%	+$88	﹤0.01%	4513
2015 Q1	$1K	Sell	173 -63	-27%	-$364	﹤0.01%	4842
2014 Q4	$2K	Buy	+236	New	+$2K	﹤0.01%	3968

Simplex Trading's RXII Position: Q4 2016 in Review

Simplex Trading sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 18,771 shares — an estimated $6K sold.

Simplex Trading first reported a position in RXII in Q3 2015 and held it in 5 quarters. The position peaked at $21K in Q2 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Simplex Trading reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Simplex Trading sold 18,771 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $6K.
Simplex Trading first reported a position in GALENA BIOPHARMA INC COM in Q3 2015 and held it in 5 quarters.
Simplex Trading's GALENA BIOPHARMA INC COM position peaked at $21K in Q2 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Simplex Trading's 13F filing for Q4 2016, filed 11 Jan 2017.